Epigenomic abnormalities and human diseases: genetic dysfunction without genetic mutation DOI Open Access

Kenichiro Hata

Japanese Journal of Thrombosis and Hemostasis, Journal Year: 2021, Volume and Issue: 32(5), P. 619 - 624

Published: Jan. 1, 2021

エピゲノムは,遺伝子の配列変化を伴わずに機能を変化させ,細胞分裂を経ても安定して伝わる情報である.近年その分子的実体が明らかになると共に.エピゲノム異常による病因病態の詳細が解明されつつある.またエピゲノムは,環境の影響を受けて変化することが知られている.その結果,胎児期や乳幼児期の不適切な環境の影響が長期遺残し,成人期の疾患素因となる可能性が示されている.また,単一遺伝子疾患が,ゲノム異常(塩基配列異常)を伴わずにエピゲノム異常により発症した例も報告されつつあり,これまで原因不明とされてきた様々な疾患の病因病態解明に寄与することが期待される.

Language: Английский

The ageing epigenome and its rejuvenation DOI
Weiqi Zhang, Jing Qu, Guang‐Hui Liu

et al.

Nature Reviews Molecular Cell Biology, Journal Year: 2020, Volume and Issue: 21(3), P. 137 - 150

Published: Feb. 4, 2020

Language: Английский

Citations

390

Mitochondrial mutations and mitoepigenetics: Focus on regulation of oxidative stress-induced responses in breast cancers DOI
Kuo Chen, Pengwei Lu, Narasimha M. Beeraka

et al.

Seminars in Cancer Biology, Journal Year: 2020, Volume and Issue: 83, P. 556 - 569

Published: Oct. 6, 2020

Language: Английский

Citations

167

Mechanisms of ageing: growth hormone, dietary restriction, and metformin DOI
Jan Sher Khan,

Ida Pernicova,

Kiran Nisar

et al.

The Lancet Diabetes & Endocrinology, Journal Year: 2023, Volume and Issue: 11(4), P. 261 - 281

Published: Feb. 24, 2023

Language: Английский

Citations

19

Epigenetic deregulation in cancer: Enzyme players and non-coding RNAs DOI Creative Commons
Ammad Ahmad Farooqı, Sundas Fayyaz, Palmiro Poltronieri

et al.

Seminars in Cancer Biology, Journal Year: 2020, Volume and Issue: 83, P. 197 - 207

Published: July 29, 2020

Data obtained from cutting-edge research have shown that deregulated epigenetic marks are critical hallmarks of cancer. Rapidly emerging scientific evidence has helped in developing a proper understanding the mechanisms leading to control cellular functions, changes chromatin accessibility, transcription and translation, post-translational modifications. Firstly, DNA methylation demethylation introduced, as well modifications RNA, with particular focus on N6-methyladenosine (m6A), discussing effects these normal cells malignancies. Then, modifying proteins remodelling complexes discussed. Many enzymes accessory been found mutated or undergone differential splicing, defective protein complexes. Epigenetic acting nucleosomes by polycomb repressive SWI/SNF nucleosome assembly/disassembly, main genes linked cancers, reviewed. Among histones other erasing reversible histone deacetylases (HDACs). Sirtuins interest since most not only deacylate proteins, but also post-translationally modify adding Mono-ADP-ribose (MAR) moiety. MAR can be read MACRO-domain containing such MacroH2A1, specific function assembly. Finally, recent advances presented non-coding RNAs scaffold function, prospecting their role assembly complexes, recruiting enzyme players regions. Lastly, imbalance metabolites production due mitochondrial dysfunction is presented, potential inhibit enzymes, either writers, readers erasers epitranscriptome marks. In perspectives, studies overwied drugs under development aiming limit excessive activities reactivate for therapeutic application. This knowledge may lead novel personalised medicine cancer patients.

Language: Английский

Citations

40

Metformin's Mechanisms in Attenuating Hallmarks of Aging and Age-Related Disease DOI Creative Commons
Fangfang Cheng, Yanli Liu,

Jang Du

et al.

Aging and Disease, Journal Year: 2022, Volume and Issue: 13(4), P. 970 - 970

Published: Jan. 1, 2022

Aging is a major global challenge, and there growing demand for new strategies to address the burden of aging. The intensive search antiaging agents has led discovery variety drugs that promote extension healthspan and/or life. Metformin safe, effective, globally affordable antihyperglycemic agent gained much attention in recent years as potential treatment. been shown significantly delay onset age-related diseases increase lifespan several model organisms. In this paper, we reviewed aging hallmarks role metformin countering these hallmarks. We examined beneficial effects on feasibility an extend healthspan. Finally, discussed research directions better understand translational humans.

Language: Английский

Citations

27

Metabolism navigates neural cell fate in development, aging and neurodegeneration DOI Creative Commons
Larissa Traxler,

Jessica Lagerwall,

Sophie Eichhorner

et al.

Disease Models & Mechanisms, Journal Year: 2021, Volume and Issue: 14(8)

Published: Aug. 1, 2021

ABSTRACT An uninterrupted energy supply is critical for the optimal functioning of all our organs, and in this regard human brain particularly dependent. The study metabolic pathways a major focus within neuroscience research, which supported by genetic defects oxidative phosphorylation mechanism often contributing towards neurodevelopmental disorders changes glucose metabolism presenting as hallmark feature age-dependent neurodegenerative disorders. However, recent studies have illuminated roles cellular that span far beyond mere energetics, it would be valuable to first comprehend physiological involvement neural cell fate function, subsequently reconstruct their impact on diseases brain. In Review, we discuss evidence implies master regulator identity during development. Additionally, examine type-dependent states present adult As been studied extensively crucial regulators malignant transformation cancer, reveal how knowledge gained from field cancer has aided understanding likewise controls determination stability directly wiring into epigenetic landscape. We further summarize research pertaining interplay between alterations psychiatric disorders, expose an improved control might assist development new concepts combat diseases, Alzheimer's disease.

Language: Английский

Citations

31

How can we modulate aging through nutrition and physical exercise? An epigenetic approach DOI Creative Commons
Ana Teresa Rajado, Nádia Silva, Filipa Esteves

et al.

Aging, Journal Year: 2023, Volume and Issue: unknown

Published: April 20, 2023

The World Health Organization predicts that by 2050, 2.1 billion people worldwide will be over 60 years old, a drastic increase from only 1 in 2019. Considering these numbers, strategies to ensure an extended "healthspan" or healthy longevity are urgently needed. present study approaches the promotion of healthspan epigenetic perspective. Epigenetic phenomena modifiable response individual's environmental exposures, and therefore link environment their gene expression pattern. studies demonstrate aging is associated with decondensation chromatin, leading altered heterochromatin structure, which promotes accumulation errors. In this review, we describe how impacts epigenetics nutrition physical exercise can positively impact process, point view. Canonical histones replaced histone variants, concomitant post-translational modifications. A slight DNA methylation at promoters has been observed, represses transcription previously active genes, parallel global genome hypomethylation. Aging also deregulation - usually provided non-coding RNAs both repression transcribed genes repressed genes. Age-associated events less common individuals lifestyle, including balanced nutrition, caloric restriction exercise. Healthy more tightly condensed fewer PTMs greater regulation ncRNAs.

Language: Английский

Citations

12

Nuclear organization and regulation of the differentiated state DOI Creative Commons
Eliya Bitman-Lotan, Amir Orian

Cellular and Molecular Life Sciences, Journal Year: 2021, Volume and Issue: 78(7), P. 3141 - 3158

Published: Jan. 28, 2021

Regulation of the differentiated identity requires active and continued supervision. Inability to maintain state is a hallmark aging aging-related disease. To cellular identity, network nuclear regulators devoted silencing previous non-relevant gene programs. This involves transcription factors, epigenetic regulators, localization silent genes heterochromatin. Together, supervisors mold unique environment cell. review describes recent discoveries regarding mechanisms that supervise protect from de-differentiation, tumorigenesis, attenuate forced somatic cell reprograming. The focuses on involved in H3K9me3-decorated heterochromatin importance lamins identity. We outline how biophysical properties these factors are self-compartmentalization Finally, we discuss relevance age-related

Language: Английский

Citations

26

Metformin inhibits the histone methyltransferase CARM1 and attenuates H3 histone methylation during gluconeogenesis DOI Creative Commons

Sinjini Dhang,

Atanu Mondal,

Chandrima Das

et al.

Journal of Biological Chemistry, Journal Year: 2025, Volume and Issue: unknown, P. 108271 - 108271

Published: Feb. 1, 2025

Hyperglycemia is a hallmark of metabolic disorders, yet the precise mechanisms linking epigenetic regulation to glucose metabolism remain underexplored. Coactivator-associated arginine methyltransferase 1 (CARM1), type I histone methyltransferase, promotes transcriptional activation through methylation H3 at residues H3R17 and H3R26. Here, we identify novel mechanism by which metformin, widely prescribed antidiabetic drug, inhibits CARM1 activity. Using biochemical biophysical assays, show that metformin binds substrate-binding site CARM1, reducing levels in CARM1-overexpressing hepatic cells liver tissues from metformin-fed mice. This modulation suppresses expression gluconeogenic enzymes (G6Pase, FBPase, PCK1), thereby reversing CARM1-induced glycolytic suppression regulating gluconeogenesis. Importantly, does not alter protein its recruitment gene promoters but diminishes H3R17me2a marks these loci. Our findings reveal previously unrecognized action, offering new therapeutic insights for hyperglycemia management.

Language: Английский

Citations

0

A case of CHD2 variant-associated psychosis and response to treatment DOI
Mark Ainsley Colijn,

Ignacio Ortega,

Julie Lauzon

et al.

Psychiatric Genetics, Journal Year: 2025, Volume and Issue: unknown

Published: March 21, 2025

Although psychotic symptoms have occasionally been associated with pathogenic CHD2 variants, few articles provided phenotypic information in this respect or described treatment response. We describe an 18-year-old female a 15q26.1 interstitial deletion that disrupts CHD2, who at age 12 developed variety of responded well to quetiapine therapy. She also exhibited improvement her cognitive functioning, language skills, and social responsiveness, which coincided the initiation metformin. This is only third report characterize antipsychotic response individual harboring variant, first do so relation quetiapine. anecdotal, develop variants may respond atypical therapy, metformin additional benefits population behavioral/social deficits. However, more evidence needed before any firm conclusions can be drawn.

Language: Английский

Citations

0